Trial Profile
A prospective trial assessing the impact of type of calcineurin inhibitor (CNI) on incidence of post renal transplant Tuberculosis.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Mar 2016
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary) ; Ciclosporin
- Indications Tuberculosis
- Focus Therapeutic Use
- 04 Mar 2016 New trial record